Andre Monteiro da Rocha1, Guadalupe Guerrero-Serna2, Adam Helms2, Carly Luzod2, Sergey Mironov2, Mark Russell3, José Jalife2, Sharlene M Day2, Gary D Smith4, Todd J Herron5. 1. Department of Internal Medicine, Center for Arrhythmia Research, University of Michigan, Ann Arbor, MI 48109, United States; Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI 48109, United States. 2. Department of Internal Medicine, Center for Arrhythmia Research, University of Michigan, Ann Arbor, MI 48109, United States. 3. Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109, United States. 4. Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI 48109, United States. Electronic address: smithgd@umich.edu. 5. Department of Internal Medicine, Center for Arrhythmia Research, University of Michigan, Ann Arbor, MI 48109, United States. Electronic address: toddherr@umich.edu.
Abstract
AIMS: Mutations of cardiac sarcomere genes have been identified to cause HCM, but the molecular mechanisms that lead to cardiomyocyte hypertrophy and risk for sudden death are uncertain. The aim of this study was to examine HCM disease mechanisms at play during cardiac differentiation of human HCM specific pluripotent stem cells. METHODS AND RESULTS: We generated a human embryonic stem cell (hESC) line carrying a naturally occurring mutation of MYPBC3 (c.2905 +1 G >A) to study HCM pathogenesis during cardiac differentiation. HCM-specific hESC-derived cardiomyocytes (hESC-CMs) displayed hallmark aspects of HCM including sarcomere disarray, hypertrophy and impaired calcium impulse propagation. HCM hESC-CMs presented a transient haploinsufficiency of cMyBP-C during cardiomyocyte differentiation, but by day 30 post-differentiation cMyBP-C levels were similar to control hESC-CMs. Gene transfer of full-length MYBPC3 during differentiation prevented hypertrophy, sarcomere disarray and improved calcium impulse propagation in HCM hESC-CMs. CONCLUSION(S): These findings point to the critical role of MYBPC3 during sarcomere assembly in cardiac myocyte differentiation and suggest developmental influences of MYBPC3 truncating mutations on the mature hypertrophic phenotype.
AIMS: Mutations of cardiac sarcomere genes have been identified to cause HCM, but the molecular mechanisms that lead to cardiomyocyte hypertrophy and risk for sudden death are uncertain. The aim of this study was to examine HCM disease mechanisms at play during cardiac differentiation of human HCM specific pluripotent stem cells. METHODS AND RESULTS: We generated a human embryonic stem cell (hESC) line carrying a naturally occurring mutation of MYPBC3 (c.2905 +1 G >A) to study HCM pathogenesis during cardiac differentiation. HCM-specific hESC-derived cardiomyocytes (hESC-CMs) displayed hallmark aspects of HCM including sarcomere disarray, hypertrophy and impaired calcium impulse propagation. HCM hESC-CMs presented a transient haploinsufficiency of cMyBP-C during cardiomyocyte differentiation, but by day 30 post-differentiation cMyBP-C levels were similar to control hESC-CMs. Gene transfer of full-length MYBPC3 during differentiation prevented hypertrophy, sarcomere disarray and improved calcium impulse propagation in HCM hESC-CMs. CONCLUSION(S): These findings point to the critical role of MYBPC3 during sarcomere assembly in cardiac myocyte differentiation and suggest developmental influences of MYBPC3 truncating mutations on the mature hypertrophic phenotype.
Authors: Todd J Herron; Eric Devaney; Lakshmi Mundada; Erik Arden; Sharlene Day; Guadalupe Guerrero-Serna; Immanuel Turner; Margaret Westfall; Joseph M Metzger Journal: FASEB J Date: 2009-10-02 Impact factor: 5.191
Authors: Samantha P Harris; Christopher R Bartley; Timothy A Hacker; Kerry S McDonald; Pamela S Douglas; Marion L Greaser; Patricia A Powers; Richard L Moss Journal: Circ Res Date: 2002-03-22 Impact factor: 17.367
Authors: B K McConnell; K A Jones; D Fatkin; L H Arroyo; R T Lee; O Aristizabal; D H Turnbull; D Georgakopoulos; D Kass; M Bond; H Niimura; F J Schoen; D Conner; D A Fischman; C E Seidman; J G Seidman; D H Fischman Journal: J Clin Invest Date: 1999-11 Impact factor: 14.808
Authors: Nicole C Dubois; April M Craft; Parveen Sharma; David A Elliott; Edouard G Stanley; Andrew G Elefanty; Anthony Gramolini; Gordon Keller Journal: Nat Biotechnol Date: 2011-10-23 Impact factor: 54.908
Authors: David Barefield; Mohit Kumar; Joshua Gorham; Jonathan G Seidman; Christine E Seidman; Pieter P de Tombe; Sakthivel Sadayappan Journal: J Mol Cell Cardiol Date: 2014-11-25 Impact factor: 5.000
Authors: Matthew J Birket; Marcelo C Ribeiro; Georgios Kosmidis; Dorien Ward; Ana Rita Leitoguinho; Vera van de Pol; Cheryl Dambrot; Harsha D Devalla; Richard P Davis; Pier G Mastroberardino; Douwe E Atsma; Robert Passier; Christine L Mummery Journal: Cell Rep Date: 2015-10-17 Impact factor: 9.423
Authors: Lu Han; Yang Li; Jason Tchao; Aaron D Kaplan; Bo Lin; You Li; Jocelyn Mich-Basso; Agnieszka Lis; Narmeen Hassan; Barry London; Glenna C L Bett; Kimimasa Tobita; Randall L Rasmusson; Lei Yang Journal: Cardiovasc Res Date: 2014-09-10 Impact factor: 10.787
Authors: Adam S Helms; Vi T Tang; Thomas S O'Leary; Sabrina Friedline; Mick Wauchope; Akul Arora; Aaron H Wasserman; Eric D Smith; Lap Man Lee; Xiaoquan W Wen; Jordan A Shavit; Allen P Liu; Michael J Previs; Sharlene M Day Journal: JCI Insight Date: 2020-01-30
Authors: Justin Davis; Ahmad Chouman; Jeffery Creech; Andre Monteiro da Rocha; Daniela Ponce-Balbuena; Eric N Jimenez Vazquez; Ruthann Nichols; Andrey Lozhkin; Nageswara R Madamanchi; Katherine F Campbell; Todd J Herron Journal: JCI Insight Date: 2021-05-24
Authors: Maksymilian Prondzynski; Elisabeth Krämer; Sandra D Laufer; Aya Shibamiya; Ole Pless; Frederik Flenner; Oliver J Müller; Julia Münch; Charles Redwood; Arne Hansen; Monica Patten; Thomas Eschenhagen; Giulia Mearini; Lucie Carrier Journal: Mol Ther Nucleic Acids Date: 2017-05-17